⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12813 | 1.00 | — | — | |
| SCHEMBL2250575 | 1.00 | — | — | |
| SCHEMBL129150 | 0.95 | — | — | |
| SCHEMBL825746 | 0.80 | — | — | |
| SCHEMBL834059 | 0.80 | — | — | |
| Diethylamine SCHEMBL27883551 | 0.76 | TP53 (0.42) | — | |
| Fluoride Ion SCHEMBL816398 | 0.67 | MGLL (0.32) | — | |
| SCHEMBL23810072 | 0.61 | CYP2D6 (0.33) | — | |
| SCHEMBL6926105 | 0.60 | MGLL (0.40) | — | |
| SCHEMBL42220 | 0.60 | MGLL (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197711-A1 | Combination Therapy for Cancer Treatment | REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-06-20 | — | — | US | claimed |
| US-20240124419-A1 | SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-04-18 | — | — | US | claimed |
| EP-4313029-A1 | COMBINATION THERAPY FOR CANCER TREATMENT | The Regents of The University of Michigan (US) | 2024-02-07 | — | — | EP | claimed |
| CN-117337175-A | Combination Therapy for Cancer Treatment | 密歇根大学董事会 | 2024-01-02 | — | — | CN | claimed |
| EP-4288416-A2 | SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF | The Regents Of The University Of Michigan (US) | 2023-12-13 | — | — | EP | claimed |
| US-20230098205-A1 | INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-03-30 | — | — | US | claimed |
| US-20230097789-A1 | INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF THE SAME | UNIV MICHIGAN REGENTS (US) | 2023-03-30 | — | — | US | claimed |
| EP-4114387-A1 | INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF THE SAME | The Regents of The University of Michigan (US) | 2023-01-11 | — | — | EP | claimed |
| EP-4114386-A1 | INHIBITORS OF EGFR, KRAS, BRAF, AND OTHER TARGETS AND USE OF THE SAME | The Regents of The University of Michigan (US) | 2023-01-11 | — | — | EP | claimed |
| WO-2022169834-A2 | SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-08-11 | — | — | WO | claimed |
| EP-1165566-B1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE AS INHIBITORS OF CYTOKINE MEDIATED DISEASE | ASTRAZENECA AB (SE) | 2003-08-20 | — | — | EP | claimed |
| US-6548514-B1 | Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders | ASTRAZENECA AB (SE) | 2003-04-15 | — | — | US | claimed |
| JP-2002540112-A | — | — | 2002-11-26 | — | — | JP | claimed |
| JP-2002539187-A | — | — | 2002-11-19 | — | — | JP | claimed |
| EP-1165566-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE AS INHIBITORS OF CYTOKINE MEDIATED DISEASE | AstraZeneca AB (SE) | 2002-01-02 | — | — | EP | claimed |
| EP-1163212-A1 | AMIDE DERIVATIVES | AstraZeneca AB (SE) | 2001-12-19 | — | — | EP | claimed |
| EP-1163237-A1 | AMIDE DERIVATIVES | AstraZeneca AB (SE) | 2001-12-19 | — | — | EP | claimed |
| WO-2000056738-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE AS INHIBITORS OF CYTOKINE MEDIATED DISEASE | ASTRAZENECA AB (SE) | 2000-09-28 | — | — | WO | claimed |
| WO-2000055120-A1 | AMIDE DERIVATIVES | ASTRAZENECA AB (SE) | 2000-09-21 | — | — | WO | claimed |
| WO-2000055153-A1 | AMIDE DERIVATIVES | ASTRAZENECA AB (SE) | 2000-09-21 | — | — | WO | claimed |